AD

Name
AD
Alternate names
ADIC
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for AD
Name
Alternate Names
Deticene
Detimedac
Dimethyl-triazeno-imidazole-carboxamide
DTIC-Dome
Fauldetic
Imidazole carboxamide
WR-139007
Abbreviations
DIC
DTIC
ICDT
ICT
Category
Chemotherapy
Subcategory
Antimetabolite
Nonclassic alkylating agent
NSC Number
45388
045388
Primary Site
Hodgkin's disease
Neuroblastoma
Soft tissue sarcomas
Histology
None
Remarks
FDA approved on Hodgkin's lymphoma, and metastatic melanoma.
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
NSC Number
123127
Primary Site
multiple myeloma
ovarian
pancreatic
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded